Docosahexaenoic Acid (DHA) Supplementation During Pregnancy Reduces the Risk of Preterm Birth in Threatened Preterm Labor
Condition(s):Pregnant Women Diagnosed With Threatened Preterm LaborLast Updated:March 8, 2024Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Pregnant Women Diagnosed With Threatened Preterm LaborLast Updated:March 8, 2024Not yet recruiting
Condition(s):PreTerm Labor; Threatened Preterm Labor; Preterm BirthLast Updated:December 5, 2023Recruiting
Condition(s):Preterm Labor With Preterm DeliveryLast Updated:April 15, 2021Unknown status
Condition(s):Preterm Labor; Preterm BirthLast Updated:May 2, 2022Recruiting
Condition(s):Pregnancy Preterm; Labor; Irregular; Preterm LaborLast Updated:February 12, 2020Completed
Condition(s):Preterm LaborLast Updated:January 10, 2023Completed
Condition(s):Labor Onset and Length AbnormalitiesLast Updated:January 21, 2022Completed
Condition(s):Preterm LaborLast Updated:August 2, 2023Not yet recruiting
Condition(s):Preterm Labor Without Delivery; Pregnancy PretermLast Updated:September 15, 2022Recruiting
Condition(s):Breech PresentationLast Updated:February 22, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.